Author:
Menter Alan,Cather Jennifer C.,Baker Diane,Farber Harold F.,Lebwohl Mark,Darif Mohamed
Reference10 articles.
1. A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis;Krueger;J Am Acad Dermatol,2002
2. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis;Lebwohl;Arch Dermatol,2003
3. Remittive effects of intramuscular alefacept in psoriasis;Gordon;J Drugs Dermatol,2003
4. A 50% reduction in the Psoriasis Area and Severity Index (PASI) is a clinically significant endpoint in the assessment of psoriasis;Carlin;J Am Acad Dermatol,2004
5. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial;Ellis;Am J Clin Dermatol,2003
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献